ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.80
-1.58% today
Updated 2026-04-29
Market cap
$10.89B
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$9 – $28
Volume
5.1M
Elanco Animal Health (ELAN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.60M | $155.90M | $173.80M | $487.30M | $224.10M | $-41.00M | $483.00M | $452.00M | $271.00M | $541.00M | $560.00M |
| Capital expenditures | $100.10M | $110.30M | $98.60M | $134.50M | $197.40M | $310.90M | $197.00M | $184.00M | $154.00M | $147.00M | $276.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $13.40M | $20.40M | $25.00M | $26.00M | $49.40M | $47.00M | $66.00M | $59.00M | $46.00M | $55.00M | $68.00M |
| Free cash flow | $-93.50M | $45.60M | $75.20M | $352.80M | $26.70M | $-351.90M | $286.00M | $268.00M | $117.00M | $394.00M | $284.00M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $325.10M | $-315.50M | $133.70M | $163.00M | $-276.00M | — | — | — |